Skip to main content
Top
Published in: BMC Pediatrics 1/2021

Open Access 01-12-2021 | Anemia | Research article

Time to detection of anemia and its predictors among children living with HIV at Debre Tabor and University of Gondar Compressive Specialized Hospitals, 2020: a multicentre retrospective follow-up study

Authors: Ermias Sisay Chanie, Dejen Getanh Feleke, Sintayehu Asnakew, Fisha Alebel GebreEyesus, Aragaw Tesfaw, Wubet Alebachew Bayih, Agimasie Tigabu, Yared Asmare Anyalem, Abraham Tsedalu Amare, Demeke Mesfin Belay, Fentaw Teshome Dagnaw, Biruk Beletew Abate

Published in: BMC Pediatrics | Issue 1/2021

Login to get access

Abstract

Background

Even though antiretroviral therapy access for HIV infected children increased dramatically, anemia have been continued as a challenge regardless of a cluster of differentiation (CD4) count and viral load. Hence, this study aimed to assess the time to detection of anemia and its predictors among children living with HIV at Debre Tabor and university of Gondar compressive specialized hospital, 2020.

Methods

A retrospective follow-up study was conducted from January 2010 to December 2018. A total of 372 children under the age of 15 who had received ART were included in the study. Data were collected from children’s medical charts and ART registration logbook using a standard checklist. Besides, the data were entered into Epi data 4.2.2 and then exported to Stata 14.0 for further analysis. The Cox regression model, the variables having P-value ≤.05 with 95% CIs in multivariable analysis were declared as statistically significant for anemia.

Result

The mean (±SD) of follow-up periods were 56.6 ± 1.7 SD months. The overall median survival time free from anemia was 137 months, and the incidence rate of anemia was 6.9 per 100 PYO (95% CI: 5.3, 7.8). Moreover, WHO clinical staging of III/IV [AHR: 4.2, 95% CI: 1.80, 11.1], low CD4 count below threshold [AHR: 1.9, 95% CI: 1.09, 3.37], cotrimoxazole preventive therapy non-users, and poor level of adherence [(AHR: 2.4, 95% CI: 1.20, 4.85] were the main predictors of the time to detection of anemia.

Conclusion

The incidence rate of anemia in our retrospective cohort was high. The risk of anemia is present in children living with HIV infection but the risk for anemia is increased based on (WHO clinical staging III and IV, CD4 count below the threshold level, CPT non-users, and poor level of adherence). Since many of these risk factors are present routinely, even within one single patient, our clinical monitoring for anemia quarterly was fully justified as was our routine switch from standard therapies such as AZT to another regimen upon lab confirmation of anemia. Additional methods to improve cotrimoxazole preventative therapy and level of adherence are also needed.
Literature
2.
go back to reference Belperio PS, Rhew DC. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med. 2004;116(7, Supplement 1):27–43.CrossRef Belperio PS, Rhew DC. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med. 2004;116(7, Supplement 1):27–43.CrossRef
6.
go back to reference Akalu TY. Anemia and determinants among severely malnourished children admitted to Amhara regional referral hospitals. Northwest Ethiopia. 2020;2:6. Akalu TY. Anemia and determinants among severely malnourished children admitted to Amhara regional referral hospitals. Northwest Ethiopia. 2020;2:6.
8.
go back to reference Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M, et al. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis Off Publ Infect Dis Soc Am. 2004;38(10):1454–63. https://doi.org/10.1086/383031.CrossRef Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M, et al. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis Off Publ Infect Dis Soc Am. 2004;38(10):1454–63. https://​doi.​org/​10.​1086/​383031.CrossRef
11.
go back to reference Am L, K B, L M-L, M S, M Y, M A, et al. Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 1999. 2001 Jan 1;26(1):28–35. Am L, K B, L M-L, M S, M Y, M A, et al. Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 1999. 2001 Jan 1;26(1):28–35.
25.
go back to reference Melkamu MW, Gebeyehu MT, Afenigus AD, Hibstie YT, Temesgen B, Petrucka P, et al. Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study. BMC Infect Dis. 2020;20(1):50 [cited 2020 Oct 7] Available from: https://doi.org/10.1186/s12879-020-4772-y.CrossRef Melkamu MW, Gebeyehu MT, Afenigus AD, Hibstie YT, Temesgen B, Petrucka P, et al. Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study. BMC Infect Dis. 2020;20(1):50 [cited 2020 Oct 7] Available from: https://​doi.​org/​10.​1186/​s12879-020-4772-y.CrossRef
26.
go back to reference Fanta TFDR of EM of H. National Guidelines for HIV/AIDS and Nutrition:83. Fanta TFDR of EM of H. National Guidelines for HIV/AIDS and Nutrition:83.
30.
go back to reference Gebresillassie BM, Gebeyehu MB, Abegaz TM, Erku DA, Mekuria AB, Tadesse YD. Evaluation of cotrimoxazole use as a preventive therapy among patients living with HIV/AIDS at Gondar University referral hospital, northwestern Ethiopia: a retrospective cross-sectional study. HIVAIDS Auckl NZ. 2016;8:125–33. Gebresillassie BM, Gebeyehu MB, Abegaz TM, Erku DA, Mekuria AB, Tadesse YD. Evaluation of cotrimoxazole use as a preventive therapy among patients living with HIV/AIDS at Gondar University referral hospital, northwestern Ethiopia: a retrospective cross-sectional study. HIVAIDS Auckl NZ. 2016;8:125–33.
33.
go back to reference Melkamu MW, Gebeyehu MT, Afenigus AD, Hibstie YT, Temesgen B, Petrucka P, et al. Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study. BMC Infect Dis. 2020;20(1):1–12.CrossRef Melkamu MW, Gebeyehu MT, Afenigus AD, Hibstie YT, Temesgen B, Petrucka P, et al. Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study. BMC Infect Dis. 2020;20(1):1–12.CrossRef
34.
go back to reference Koye DN, Ayele TA, Zeleke BM. Predictors of mortality among children on antiretroviral therapy at a referral hospital. Northwest Ethiopia: a retrospective follows up study BMC Pediatr. 2012;12:161. Koye DN, Ayele TA, Zeleke BM. Predictors of mortality among children on antiretroviral therapy at a referral hospital. Northwest Ethiopia: a retrospective follows up study BMC Pediatr. 2012;12:161.
35.
go back to reference Wagnew F, Eshetie S, Alebel A, Tesema C, Kibret GD, Gabriel A, et al. Burden of anemia and its association with HAART in HIV infected children in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):1–9.CrossRef Wagnew F, Eshetie S, Alebel A, Tesema C, Kibret GD, Gabriel A, et al. Burden of anemia and its association with HAART in HIV infected children in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):1–9.CrossRef
43.
48.
go back to reference Lumbiganon P, Kosalaraksa P, Bunupuradah T, Boettiger D, Saphonn V, Truong KH, et al. HIV-infected children in the Asia-Pacific region with baseline severe anemia: antiretroviral therapy and outcomes. Asian Biomed. 2017;10(3):229–34. Lumbiganon P, Kosalaraksa P, Bunupuradah T, Boettiger D, Saphonn V, Truong KH, et al. HIV-infected children in the Asia-Pacific region with baseline severe anemia: antiretroviral therapy and outcomes. Asian Biomed. 2017;10(3):229–34.
49.
go back to reference Legason ID, Atiku A, Ssenyonga R, Olupot-Olupot P, Barugahare JB. Prevalence of Anaemia and Associated Risk Factors among Children in North-western Uganda: A Cross-Sectional Study. BMC Hematol. 2017;17:10.CrossRef Legason ID, Atiku A, Ssenyonga R, Olupot-Olupot P, Barugahare JB. Prevalence of Anaemia and Associated Risk Factors among Children in North-western Uganda: A Cross-Sectional Study. BMC Hematol. 2017;17:10.CrossRef
50.
go back to reference Atalell KA, Birhan Tebeje N, Ekubagewargies DT. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up studies. PloS One. 2018;13(5):e0197145.CrossRef Atalell KA, Birhan Tebeje N, Ekubagewargies DT. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up studies. PloS One. 2018;13(5):e0197145.CrossRef
Metadata
Title
Time to detection of anemia and its predictors among children living with HIV at Debre Tabor and University of Gondar Compressive Specialized Hospitals, 2020: a multicentre retrospective follow-up study
Authors
Ermias Sisay Chanie
Dejen Getanh Feleke
Sintayehu Asnakew
Fisha Alebel GebreEyesus
Aragaw Tesfaw
Wubet Alebachew Bayih
Agimasie Tigabu
Yared Asmare Anyalem
Abraham Tsedalu Amare
Demeke Mesfin Belay
Fentaw Teshome Dagnaw
Biruk Beletew Abate
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2021
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-021-02616-0

Other articles of this Issue 1/2021

BMC Pediatrics 1/2021 Go to the issue